ICON Release: New Book By Industry Thought Leaders Advocates For Re-Engineering Clinical Trials

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a global provider of drug and development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of the book “Re-Engineering Clinical Trials” (ISBN: 9780124202467), edited and co-authored by Brendan Buckley, ICON’s Chief Medical Officer, and Peter Schüler, ICON’s SVP of Global Medical and Safety Services.

Help employers find you! Check out all the jobs and post your resume.